Provectus Biopharmaceuticals Price on July 24, 2023

PVCTDelisted Stock  USD 0.11  0.00  0.00%   
If you're considering investing in Provectus OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Provectus Biopharmaceutica stands at 0.11, as last reported on the 22nd of December, with the highest price reaching 0.11 and the lowest price hitting 0.11 during the day. We have found eighteen technical indicators for Provectus Biopharmaceutica, which you can use to evaluate the volatility of the company. Please check Provectus Biopharmaceutica's Variance of 32.57, coefficient of variation of (1,840), and Risk Adjusted Performance of (0.03) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Provectus OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PVCT
Based on monthly moving average Provectus Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Provectus Biopharmaceutica by adding Provectus Biopharmaceutica to a well-diversified portfolio.

Related Headline

Kezar Life Headline on 24th of July 2023

Filed transaction by Kezar Life Sciences Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Provectus Biopharmaceutica Valuation on July 24, 2023

It is possible to determine the worth of Provectus Biopharmaceutica on a given historical date. On July 24, 2023 Provectus was worth 0.11 at the beginning of the trading date compared to the closed value of 0.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Provectus Biopharmaceutica otc stock. Still, in general, we apply an absolute valuation method to find Provectus Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Provectus Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Provectus Biopharmaceutica's related companies.
 Open High Low Close Volume
  0.11    0.11    0.11    0.11    46,357  
07/24/2023
  0.11    0.11    0.11    0.11    86,014  
  0.11    0.11    0.11    0.11    0.00  
Backtest Provectus Biopharmaceutica  |  Provectus Biopharmaceutica History  |  Provectus Biopharmaceutica Valuation   PreviousNext  
Open Value
0.11
0.11
Closing Value
0.11
Upside

Provectus Biopharmaceutica Trading Date Momentum on July 24, 2023

On December 22 2024 Provectus Biopharmaceuticals was traded for  0.11  at the closing time. The top price for the day was 0.11  and the lowest listed price was  0.11 . There was no trading activity during the period 0.0. Lack of trading volume on December 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% .

Provectus Biopharmaceutica Fundamentals Correlations and Trends

By evaluating Provectus Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Provectus Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Provectus financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Provectus Biopharmaceutica OTC Stock history

Provectus Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Provectus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Provectus Biopharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Provectus Biopharmaceutica stock prices may prove useful in developing a viable investing in Provectus Biopharmaceutica
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee. Provectus Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Provectus Biopharmaceutica OTC Stock Technical Analysis

Provectus Biopharmaceutica technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Provectus Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Provectus Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Provectus Biopharmaceutica Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Provectus Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Provectus Biopharmaceutica December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Provectus Biopharmaceutica otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Provectus Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Provectus Biopharmaceutica otc stock market strength indicators, traders can identify Provectus Biopharmaceuticals entry and exit signals to maximize returns

Provectus Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Provectus Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Provectus OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Provectus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Provectus OTC Stock

If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency